标题
New horizons in treatment of osteoporosis
作者
关键词
Osteoporosis, Treatment, Fractures, Antiresorptive, Anabolic agents, Personalized medicine, Plants
出版物
DARU-Journal of Pharmaceutical Sciences
Volume 25, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-02-07
DOI
10.1186/s40199-017-0167-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- New horizons in osteoporosis therapies
- (2016) Torben Harsløf et al. CURRENT OPINION IN PHARMACOLOGY
- Exploration of individuality in drug metabolism by high-throughput metabolomics: The fast line for personalized medicine
- (2016) Oxana Trifonova et al. DRUG DISCOVERY TODAY
- Implementation of personalized medicine for fracture risk assessment in osteoporosis
- (2016) Seijiro Mori et al. Geriatrics & Gerontology International
- Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders: A New Approach to Novel Therapeutic Agents
- (2016) H.-S. Ejtahed et al. HORMONE AND METABOLIC RESEARCH
- Natural products for treatment of bone erosive diseases: The effects and mechanisms on inhibiting osteoclastogenesis and bone resorption
- (2016) Jing An et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Comparative efficacy of bisphosphonates in short-term fracture prevention for primary osteoporosis: a systematic review with network meta-analyses
- (2016) J. Zhou et al. OSTEOPOROSIS INTERNATIONAL
- A Systematic Review of in vitro Studies Conducted on Effect of Herbal Products on Secretion of Insulin from Langerhans Islets
- (2016) Mohammad Abdollahi et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Long Term Bisphosphonate Use in Osteoporotic Patients; A Step Forward, Two Steps Back
- (2016) Pooneh Salari et al. JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
- Current approaches to osteoporosis treatment
- (2015) Sian Yik Lim et al. CURRENT OPINION IN RHEUMATOLOGY
- Appropriate models for novel osteoporosis drug discovery and future perspectives
- (2015) Luigi Gennari et al. Expert Opinion on Drug Discovery
- The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2015) Dennis M. Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of Discontinuing Treatment With Blosozumab: Follow-up Results of a Phase 2 Randomized Clinical Trial in Postmenopausal Women With Low Bone Mineral Density
- (2015) Christopher P Recknor et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone biology, signaling pathways, and therapeutic targets for osteoporosis
- (2015) Nicole M. Iñiguez-Ariza et al. MATURITAS
- Burden of Illness for Osteoporotic Fractures Compared With Other Serious Diseases Among Postmenopausal Women in the United States
- (2015) Andrea Singer et al. MAYO CLINIC PROCEEDINGS
- A 7-year randomized, placebo-controlled trial assessing the long-term efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis
- (2015) Santiago Palacios et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women
- (2015) Barry S Komm et al. Expert Review of Clinical Pharmacology
- Romosozumab and Blosozumab: Alternative Drugs of Mechanical Strain-Related Stimulus Toward a Cure for Osteoporosis
- (2015) Toshihiro Sugiyama et al. Frontiers in Endocrinology
- Odanacatib: a review of its potential in the management of osteoporosis in postmenopausal women
- (2015) Roland D. Chapurlat Therapeutic Advances in Musculoskeletal Disease
- Efficacy and safety of currently marketed anti-osteoporosis medications
- (2014) J.Y. Reginster et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial
- (2014) JoAnn V. Pinkerton et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Romosozumab in Postmenopausal Women with Low Bone Mineral Density
- (2014) Michael R. McClung et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sclerostin inhibition reverses systemic, periarticular and local bone loss in arthritis
- (2013) Xiao-Xiang Chen et al. ANNALS OF THE RHEUMATIC DISEASES
- Osteoporosis in older men: Recent advances in pathophysiology and treatment
- (2013) Michaël Laurent et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Epigenetic mechanisms in bone
- (2013) Peter Vrtačnik et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Phytoestrogens in Postmenopause: The State of the Art from a Chemical, Pharmacological and Regulatory Perspective
- (2013) Elisabetta Poluzzi et al. CURRENT MEDICINAL CHEMISTRY
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis
- (2013) Nelson Watts et al. Endocrine Practice
- Osteoporosis treatment: Focus on safety
- (2013) Ian R. Reid European Journal of Internal Medicine
- Pharmacologic Management of Osteoporosis
- (2013) Michael Aynardi et al. JOURNAL OF HAND SURGERY-AMERICAN VOLUME
- Herbal preparations for the menopause: Beyond isoflavones and black cohosh
- (2013) Herman T. Depypere et al. MATURITAS
- Causes, consequences, and treatment of osteoporosis in men
- (2013) Jameela Banu Drug Design Development and Therapy
- Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline
- (2012) Nelson B. Watts et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Effect of vitamin D on insulin resistance and anthropometric parameters in Type 2 diabetes; a randomized double-blind clinical trial
- (2012) Ramin Heshmat et al. DARU-Journal of Pharmaceutical Sciences
- Terapia gênica para osteoporose
- (2011) Rafael Pacheco da Costa et al. Acta Ortopedica Brasileira
- Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen, or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07)
- (2011) K. Zaman et al. ANNALS OF ONCOLOGY
- Safety and efficacy of the cathepsin K inhibitor ONO-5334 in postmenopausal osteoporosis: The OCEAN study
- (2011) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)
- (2011) Dennis M Black et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bone remodelling at a glance
- (2011) J. C. Crockett et al. JOURNAL OF CELL SCIENCE
- Osteoporosis Update
- (2011) Kerri Durnell Schuiling et al. JOURNAL OF MIDWIFERY & WOMENS HEALTH
- An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis
- (2011) Barry S. Komm et al. MATURITAS
- Synergism between resveratrol and other phytochemicals: Implications for obesity and osteoporosis
- (2011) Srujana Rayalam et al. MOLECULAR NUTRITION & FOOD RESEARCH
- A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Interpretation and use of FRAX in clinical practice
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporotic Fractures
- (2011) Sangeeta Budhia et al. PHARMACOECONOMICS
- Prevention of bone resorption by intake of phytoestrogens in postmenopausal women: a meta-analysis
- (2010) Pooneh Salari Sharif et al. AGE
- Obesity, diabetes mellitus and last but not least, osteoporosis
- (2010) Francisco J. A. de Paula et al. Arquivos Brasileiros de Endocrinologia e Metabologia
- Effects of soy isoflavone supplements on bone turnover markers in menopausal women: Systematic review and meta-analysis of randomized controlled trials
- (2010) Kyoko Taku et al. BONE
- All Bisphosphonates Are (or May Not Be) the Same: Potential Reasons for Clinical Differences
- (2010) Paul D. Miller JOURNAL OF WOMENS HEALTH
- Are All Bisphosphonates the Same? Potential Reasons for Clinical Differences: A Perspective
- (2010) James A. Simon JOURNAL OF WOMENS HEALTH
- Lasofoxifene in Postmenopausal Women with Osteoporosis
- (2010) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Current, new and future treatments of osteoporosis
- (2010) Pooneh Salari Sharif et al. RHEUMATOLOGY INTERNATIONAL
- The effect of n-3 fatty acids on bone biomarkers in Iranian postmenopausal osteoporotic women: a randomized clinical trial
- (2009) Pooneh Salari Sharif et al. AGE
- Effect of long-term intervention of soy isoflavones on bone mineral density in women: A meta-analysis of randomized controlled trials
- (2009) Jing Liu et al. BONE
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Relationship among insulinlike growth factor I concentrations, bone mineral density, and biochemical markers of bone turnover in postmenopausal women
- (2008) Iraj Nabipour et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Ibandronate for the prevention of nonvertebral fractures: a pooled analysis of individual patient data
- (2008) A. Cranney et al. OSTEOPOROSIS INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now